Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$356,633
+$90,640 QoQ
Shares Held
45,431
-41.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 150 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$3,211,780
PutShares
224,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ABCL ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ABCL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $356,633 | 45,431 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $265,993 | 77,776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $384,709 | 76,483 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $175,183 | 51,074 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $1,092,624 | 420,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,381,032 | 466,565 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,053,154 | 453,235 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $174,913 | 30,633 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,002,623 | 435,353 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,312,706 | 512,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,071,705 | 1,468,396 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,792,201 | 2,447,404 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,448,299 | 2,775,359 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,741,837 | 1,102,520 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $283,695 | 29,097 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,211,780 | 224,600 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $945,387 | 66,111 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,500,984 | 224,600 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $514,887 | 25,693 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||